by APFLI | Aug 30, 2006 | Contraception - Chemical Methods / Hormonal Contraception / Emergency / Morning After Pill
On July 31, 2006, the U.S. Food and Drug Administration (FDA) announced that it was working with the manufacturer of the Plan B. "Morning after Pill," Duramed Research, Inc., to resolve the remaining policy issues preventing Plan B from being sold...
by APFLI | Aug 27, 2006 | Birth Control Archive
AAPLOG's Press Release on the recent FDA ruling giving Plan B OTC status for women over 17 years old: FDA DECISION ON PLAN B IS BAD MEDICINE FOR WOMEN The FDA's recent decision to allow over-the-counter status for Plan B "emergency...
by APFLI | Jul 31, 2006 | Birth Control Archive
FDA Reopens Debate on Over-the-Counter “Morning After Pill” Manufacturer Markets Condoms Designed for 13-16 Year-olds FDA REOPENS DEBATE ON OVER-THE-COUNTER "MORNING AFTER PILL". The United States’ Food and Drug Administration...
by APFLI | Jun 4, 2006 | Birth Control Archive
Ecuador Constitutional Court Unanimously Approves Prohibition on Morning After Pill Last week the Court concurred with a lower court ruling to prohibit the sale of Postinor 2 (similar to Plan B)… The suit to have the pill banned was put forward by Fernando...
by APFLI | Apr 17, 2006 | Quotes
The Morning After Pill (MAP, EC): "…Researchers have said that it acts in at least 2 ways to end a pregnancy: "a. By damaging the lining of the womb so that implantation of the human embryo – the unseen patient...
